Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

Ballard Clive; Isaacson Stuart; Mills Roger; Williams Hilde; Corbett Anne; Coate Bruce; Pahwa Rajesh; Rascol Olivier; Burn David J.

首页> 外文期刊>Journal of the American Medical Directors Association >Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

【24h】

Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

机译：当前的抗精神病药物对帕金森病精神病患者相对死亡率和不良事件的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: To establish the mortality risk and adverse events associated with the use of atypical antipsychotic medications in people with Parkinson disease psychosis (PDP) in a clinically defined trial cohort.

机译：目的：在临床定义的试验队列中，确定与非典型抗精神病药物使用有关的帕金森病精神病（PDP）患者的死亡风险和不良事件。

著录项

来源
《Journal of the American Medical Directors Association》 |2015年第10期|共7页
作者
Ballard Clive; Isaacson Stuart; Mills Roger; Williams Hilde; Corbett Anne; Coate Bruce; Pahwa Rajesh; Rascol Olivier; Burn David J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词
Parkinson disease; antipsychotics; mortality; safety; psychosis;

机译：帕金森病;抗精神病药;死亡率;安全性;精神病;

相似文献

外文文献
中文文献
专利

1. Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis [J] . Ballard Clive, Isaacson Stuart, Mills Roger, Journal of the American Medical Directors Association . 2015,第10期

机译：当前的抗精神病药物对帕金森病精神病患者相对死亡率和不良事件的影响
2. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson’s Disease [J] . Nevena Divac, Radan Stojanovi?, Katarina Savi? Vujovi?, Behavioural neurology . 2016,第1期

机译：抗精神病药在帕金森病患者治疗心理学治疗中的疗效和安全性
3. Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis:clinical, nosological and pathobiological challenges [J] . John L.Waddington 中国药理学报：英文版 . 2020,第004期

机译：帕金森氏病中的精神病和单纯性抗精神病精神分裂症谱系精神病中的帕金森病：临床，疾病学和病理生物学挑战
4. Analysis of conflicts between medication, adverse drug reactions and diseases [C] . Yasiru Nilan, Darika Sellahewa, Shalith Fernando, IEEE International Conference on Industrial and Information Systems . 2017

机译：分析药物，药物不良反应和疾病之间的冲突
5. Optimising Cueing to Improve Walking and Functional Activities in People with Parkinson's Disease when on and off Medication [D] . Baker, Katherine. 2009

机译：优化提示，以改善帕金森病的人们在帕金森病的步行和功能活动
6. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinsons Disease [O] . Nevena Divac, Radan Stojanović, Katarina Savić Vujović, 2016

机译：抗精神病药治疗帕金森氏病精神病的疗效和安全性
7. PMH3 The impact of alternative Antipsychotic Medications on the risk of adverse events in patients treated for Schizophrenia [O] . Jiang Y., Park S., McCombs J. 2015

机译：PMH3替代抗精神病药物对精神分裂症患者不良事件风险的影响

Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

摘要

著录项

相似文献

相关主题

期刊订阅